The effects of central administration of physostigmine in two models of anxiety

Pharmacology Biochemistry and Behavior

Volumn 75, Issue 2, 2003, Pages 491-496

  Sienkiewicz Jarosz, H ^a   Maciejak, Piotr ^a   Krza̧ścik, Paweł ^b   Członkowska, Agnieszka I ^b   Szyndler, Janusz ^b   Bidziński, Andrzej ^a   Kostowski, Wojciech ^a,b   Płaźnik, Adam ^a,b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Contextual fear; Intracerebroventricular injections; Intraseptal injections; Midazolam; Neophobia; Physostigmine; Rats

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; CHOLINESTERASE INHIBITOR; MIDAZOLAM; PHYSOSTIGMINE;

ANIMAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; AVERSION; CONDITIONING; CONTROLLED STUDY; DEFENSE MECHANISM; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; DRUG POTENTIATION; ENVIRONMENT; EXPLORATORY BEHAVIOR; FEAR; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRASEPTAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MICROINJECTION; NEOPHOBIA; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RAT; SEPTUM PELLUCIDUM; STEREOTAXIC SURGERY;

ANIMALIA;

EID: 0038107588     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00141-2     Document Type: Article

References (22)

1. Aloisi A.M. Sex differences in pain-induced effects on the septo-hippocampal system. Brain Res. Rev. 25:1997;397-406.
2. Bitran D., Dugan M., Renda P., Ellis R., Foley M. Anxiolytic effects of the neuroactive steroid pregnanolone (3-alpha-OH-5 beta-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum. Brain Res. 850:1999;217-224.
3. Campeau S., Falls W.A., Cullinan W.E., Helmreich D.L., Davis M., Watson S.J. Excitation and reduction of fear: behavioural and neuroendocrine indices and brain induction of the immediate-early gene c-fos. Neuroscience. 78:1997;1087-1104.
4. Cheeta S., Kenny P.J., File S.E. The role of 5-HT1A receptors in mediating the anxiogenic effects of nicotione following lateral septal administration. Eur. J. Neurosci. 12:2000;3797-3802.
5. Cheeta S., Kenny P.J., File S.E. Hippocampal and septal injections of nicotione and 8-OH-DPAT distinguish among different animal tests of anxiety. Prog. Neuropsychopharmacol. Biol. Psychiatry. 24:2000;1063-1067.
6. Degroot A., Parent M.B. Infusions of physostigmine into the hippocampus or the entorhinal cortex attenuate avoidance retention deficits produced by intra-septal infusions of the GABA agonist muscimol. Brain Res. 920:2001;10-18.
7. Degroot A., Kashluba S., Treit D. Septal GABAergic and hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Pharmacol. Biochem. Behav. 69:2001;391-399.
8. Duncan G.E., Knapp D.J., Breese G.R. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. Brain Res. 25:1996;79-91.
9. File S.E., Cheeta S., Kenny P.J. Neurobiological mechanisms by which nicotine mediates different types of anxiety. Eur. J. Pharmacol. 393:2000;231-236.
10. File S.E., Kenny P.J., Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol. Biochem. Behav. 66:2000;65-72.
11. Kask A., Nguyen H.P., von Horsten S. Neuropeptide Y Y1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone induced anxiety. Neuroscience. 104:2001;799-806.
12. Lamprea M.R., Cardenas F.P., Silveira R., Morato S., Walsh T.J. Dissociation of memory and anxiety in a repeated elevated plus maze paradigm: forebrain cholinergic mechanisms. Behav. Brain Res. 117:2000;97-105.
13. Levy M.L., Cummings J.L., Kahn-Rose R. Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease. Gerontology. 45:1999;15-22.
14. Nicoll R.A. The septo-hippocampal projection: a model cholinergic pathway. Trends Neurosci. 8:1985;533-536.
15. Pellegrino L.J., Pellegrino A.S., Cushman A.J. A stereotaxic atlas of the rat brain. 1967;Plenum, New York.
16. Pesold C., Treit D. Excitotoxic lesions of the septum produce anxiolytic effects in the elevated plus-maze and the shock-probe burying tests. Physiol. Behav. 52:1992;37-47.
17. Pesold C., Treit D. The neuroanatomical specificity of the anxiolytic effects of intra-septal infusions of midazolam. Brain Res. 26:1996;161-168.
18. Sienkiewicz-Jarosz H., Czlonkowska A.I., Siemiatkowski M., Maciejak P., Szyndler J., Plaznik A. The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia. J. Neural Transm. 107:2000;1403-1412.
19. Szyndler J., Sienkiewicz-Jarosz H., Maciejak P., Siemiatkowski M., Rokicki D., Czlonkowska A.I.et al. The anxiolytic-like effect of nicotine undergoes rapid tolerance in a model of contextual fear conditioning in rats. Pharmacol. Biochem. Behav. 69:2000;511-518.
20. Treit D., Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol. Biochem. Behav. 31:1989;959-962.
21. Wainer B.H., Levey A.I., Rye D.B., Mesulam M.M., Mufson E.J. Cholinergic and non-cholinergic septohippocampal pathways. Neurosci. Lett. 54:1985;45-52.
22. Zhu X.O., McNaughton N. Minimal changes with long-term administration of anxiolytics on septal driving of hippocampal rhythmical slow activity. Psychopharmacology. 118:1995;93-100.